chr7-98304268-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_018842.5(BAIAP2L1):c.1350C>A(p.Asp450Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000105 in 1,613,668 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_018842.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BAIAP2L1 | ENST00000005260.9 | c.1350C>A | p.Asp450Glu | missense_variant | 12/14 | 1 | NM_018842.5 | ENSP00000005260.8 | ||
BAIAP2L1 | ENST00000480580.1 | n.617C>A | non_coding_transcript_exon_variant | 2/2 | 4 | |||||
BRI3 | ENST00000491463.4 | n.72-2215G>T | intron_variant | 4 | ENSP00000459133.1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152198Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000240 AC: 6AN: 250298Hom.: 0 AF XY: 0.0000296 AC XY: 4AN XY: 135340
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1461352Hom.: 0 Cov.: 29 AF XY: 0.00000688 AC XY: 5AN XY: 726942
GnomAD4 genome AF: 0.0000525 AC: 8AN: 152316Hom.: 0 Cov.: 32 AF XY: 0.0000806 AC XY: 6AN XY: 74478
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 03, 2022 | The c.1350C>A (p.D450E) alteration is located in exon 12 (coding exon 12) of the BAIAP2L1 gene. This alteration results from a C to A substitution at nucleotide position 1350, causing the aspartic acid (D) at amino acid position 450 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at